Show newer

“Psilocybin, in contrast to any other drug we’ve tested, has this massive effect on the whole brain that was pretty unexpected,” said Dr. Nico Dosenbach, a professor of neurology at Washington University and a senior author of the study. “It was quite shocking when we saw the effect size.”

nytimes.com/2024/07/17/health/

"Psilocybin massively disrupted functional connectivity (FC) in cortex and subcortex, acutely causing more than threefold greater change than methylphenidate." rdcu.be/dN9q6

Université de Lorraine is about to sign the Barcelona Declaration on Open Research Information and moves its curating efforts towards the open bibliographic database OpenAlex. It will thus no longer provide data for rankings based on closed research information. This is in line with its commitments to the international coalition CoARA.

factuel.univ-lorraine.fr/node/

cc @BarcelonaDORI @OpenAlex @CoARAssessment

#UnivLorraine #OpenScience #ResearchAssessment #OpenAlex #barcelonadeclaration #CoARA

Two Hong Kong publishers have said a shortage of writers - both up-and-coming and experienced - posed a challenge to the local literary industry. hongkongfp.com/2024/07/18/shor

Postdoctoral Researcher - Ancient DNA

Tel Aviv University

Join our team at Tel Aviv University! Seeking a postdoc to explore ancient human DNA from sediments. Apply now to reshape genetic research!

See the full job description on jobRxiv: jobrxiv.org/job/tel-aviv-unive

#computational_biology #computer_science #data_anal...
jobrxiv.org/job/tel-aviv-unive

'The exhibition focuses on a dark period from Greece’s recent past, when democracy briefly floundered. In common with its southern European neighbours, Spain and Portugal, Greece found itself, in the seven years between 1967 and 1974, ruled by a military regime.'

ft.com/content/86e957db-f5cc-4

'When I was starting my group, I was reading advice on Twitter. A lot wasn't very useful, but somebody asked, ‘What is the single most important advice to a new PI?’ Somebody answered that it was to ‘grow slowly’, and I couldn't agree more. I tried to take the same approach: I will only hire someone in my lab if I'm absolutely sure they'll be a good fit. I think that has worked well so far.'
journals.biologists.com/dev/ar

'Yet there is another feature that is almost never viewed as a problem in “respectable circles” in Germany, or elsewhere: its huge structural savings surpluses, which have, of course, financed its huge current account surpluses. Many German economists view these as proof of Germany’s international competitiveness and insist that everybody else, especially in the Eurozone, should follow its example. This is nonsense.'

ft.com/content/2135f8c7-dd60-4

'Yet there is another feature that is almost never viewed as a problem in “respectable circles” in Germany, or elsewhere: its huge structural savings surpluses, which have, of course, financed its huge current account surpluses. Many German economists view these as proof of Germany’s international competitiveness and insist that everybody else, especially in the Eurozone, should follow its example. This is nonsense.'

ft.com/content/2135f8c7-dd60-4

'We have found that the severity of SARS-CoV-2 infection in mice can be dramatically reduced by the catalytic reduction of mROS through the action of the mCAT transgene, or treatment with the mitochondrially targeted catalytic antioxidant drug, EUK8.'

pnas.org/doi/10.1073/pnas.2321

'Há quase 3000 contratos precários de investigadores em instituições científicas, ou seja, contratos a termo com um fim previsto para os próximos anos. Destes contratos, há 1607 vínculos de cientistas que terminarão até 2026 e que, no próximo ano e meio, terão de encontrar soluções se quiserem continuar um trajecto enquanto investigadores.'
publico.pt/2024/07/17/ciencia/

The #OpenAccess 101 series kicks off Aug. 6 @ 3-4 pm ET. Sign up now to learn about the foundations of open practices - or get a refresher. Perfect for those with OA responsibilities on campus. Free & open to all. Thanks to @ScNotebook team for partnering.

sparcopen.org/news/2024/open-a

'A year ago, Caribou Biotherapeutics’ CEO was telling Fierce Biotech that the company’s natural killer (NK) cell therapy program was the “tip of the spear” for its solid tumor strategy and there were no plans to pause this work to conserve cash.
Now, with the biotech eyeing up ways to keep the money flowing into 2026, the CRISPR-focused company has decided that the preclinical CAR-NK research needs to go—along with 12% of Caribou’s workforce'

fiercebiotech.com/biotech/cari

Show older
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.